Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 37Prostatic Neoplasms 19Multiple Myeloma 17Neoplasm Metastasis 14Osteoporosis 8Neuroblastoma 6Pain 5Osteosarcoma 5Neoplasms, Plasma Cell 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Bone Diseases, Metabolic 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteonecrosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Giant Cell Tumor of Bone 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Adenocarcinoma 2

Interventions

Temozolomide 44Radiotherapy 20Magnetic Resonance Spectroscopy 13Irinotecan 13Carboplatin 11Bevacizumab 11Filgrastim 9Surgical Procedures, Operative 7Procarbazine 6sargramostim 5Vincristine 5Imatinib Mesylate 5Etoposide 5Erlotinib Hydrochloride 5Carmustine 5Biopsy 5etoposide phosphate 4Peripheral Blood Stem Cell Transplantation 4Lomustine 4Immunohistochemistry 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4temsirolimus 3poly ICLC 3aldesleukin 3Thalidomide 3Surveys and Questionnaires 3Radiation 3Polymerase Chain Reaction 3Gadolinium DTPA 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Oligodendroglioma × Zoledronic Acid × Clear all
NCT00301873 2013-02-18

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Duke University

Phase 2 Completed
60 enrolled 10 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Osteoporosis, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡